Analysis of Factors Influencing the Interchangeability of Antiepileptic Drugs


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The presence of several generics on the pharmaceutical market makes it possible to create a competitive environment and helps to reduce the costs of drug therapy. RF Government Decree No. 1154 of October 28, 2015, “On the procedure for determining the interchangeability of drugs for medical use” determines largely the fate of generics in Russia. Quality assurance of generics and the creation of a competitive environment for the procurement of pharmaceutical products by regional public health institutions in order to reduce costs were the primary drivers of this decree. However, results from substitution of antiepileptic drugs indicate a number of problems in this field. The present review is devoted to an analysis of the interchangeability problems of antiepileptic drugs.

作者简介

R. Alyautdin

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

编辑信件的主要联系方式.
Email: alyautdin@mail.ru
俄罗斯联邦, Moscow, 127051

B. Romanov

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: alyautdin@mail.ru
俄罗斯联邦, Moscow, 127051

E. Pasternak

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: alyautdin@mail.ru
俄罗斯联邦, Moscow, 127051

N. Bunyatyan

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: alyautdin@mail.ru
俄罗斯联邦, Moscow, 127051

V. Merkulov

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: alyautdin@mail.ru
俄罗斯联邦, Moscow, 127051

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media New York, 2016